Analyst Research Report Snapshot

Title:

Recordati S.p.A.

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

13 Jan 2015

Pages:

45

Type:

AcrobatPDF

Companies referenced:

Available for Immediate Download
Summary:

Recordati S.p.A. (Recordati or 'the company') is a mid-sized European pharmaceutical company marketing ethical pharmaceuticals, most of which have been in-licensed for development and marketing within specific European markets. The company markets its products in more than 100 countries, primarily in the EU. It is headquartered in Milan, Italy, and employed 3,369 people as of December 31, 2012. The company recorded revenues of E828.3 million ($1,065 million*) during the financial year ended December 2012 (FY2012), an increase of 8.7% over FY2011. The operating profit of the company was E167 million ($214.7 million*) in FY2012, an increase of 2.1% over FY2011. The net profit was E118.5 million ($152.4 million*) in FY2012, an increase of 1.8% over FY2011. *Calculated using a constant conversion rate E1 = $1.2858 for the financial year ended December 31, 2012.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.